
Biocon Limited has informed the Exchange regarding a press release dated December 07, 2021, titled "Biocon Ltd partners with Tabuk Pharmaceuticals to commercialise its speciality generic medicines in the Middle East".
Filed with NSE ·

Biocon Limited has informed the Exchange regarding a press release dated December 07, 2021, titled "Biocon Ltd partners with Tabuk Pharmaceuticals to commercialise its speciality generic medicines in the Middle East".
6ix hasn’t read this filing yet.
Follow Biocon into a list and get an email when it puts out news.
Follow Biocon